Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.17 USD | +0.83% | +3.15% | -33.27% |
Financials (USD)
Sales 2024 * | 777M | Sales 2025 * | 862M | Capitalization | 2B |
---|---|---|---|---|---|
Net income 2024 * | 192M | Net income 2025 * | 225M | EV / Sales 2024 * | 2.9 x |
Net Debt 2024 * | 260M | Net Debt 2025 * | 41.48M | EV / Sales 2025 * | 2.36 x |
P/E ratio 2024 * |
11.3
x | P/E ratio 2025 * |
9.62
x | Employees | 1,761 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 63.31% |
Latest transcript on Amphastar Pharmaceuticals, Inc.
1 day | -0.41% | ||
1 week | +5.64% | ||
Current month | -7.01% | ||
1 month | -6.42% | ||
3 months | -23.31% | ||
6 months | -9.39% | ||
Current year | -33.99% |
Managers | Title | Age | Since |
---|---|---|---|
Zi Ping Luo
FOU | Founder | 74 | 96-02-28 |
Yong Feng Zhang
CEO | Chief Executive Officer | 77 | 96-02-28 |
William Peters
DFI | Director of Finance/CFO | 56 | 14-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Prins
BRD | Director/Board Member | 67 | 03-01-31 |
William Peters
DFI | Director of Finance/CFO | 56 | 14-03-31 |
Director/Board Member | 64 | 01-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.51% | 29 M€ | -4.59% | ||
0.37% | 45 M€ | -0.39% | ||
0.30% | 27 M€ | -5.44% | - | |
0.25% | 1,026 M€ | +6.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 41.27 | +1.08% | 185 762 |
24-04-25 | 40.83 | -0.41% | 236,143 |
24-04-24 | 41 | +0.22% | 218,270 |
24-04-23 | 40.91 | +1.84% | 210,158 |
24-04-22 | 40.17 | +0.40% | 345,090 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.99% | 2B | |
+24.64% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.11% | 233B | |
+5.44% | 201B | |
-10.06% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- AMPH Stock